フロリダ州におけるクローン病の臨床試験
フロリダ州内の拠点で、クローン病に関する27件の研究が参加者を募集しています。
フロリダ州内の都市
- Miami19件の研究
- Orlando17件の研究
- Tampa10件の研究
- Kendall5件の研究
- Jacksonville4件の研究
- Hialeah4件の研究
- Spring Hill4件の研究
- Gainesville3件の研究
- Pensacola3件の研究
- Town 'n' Country3件の研究
- Clearwater3件の研究
- Lakeland3件の研究
公式研究テキスト（英語）
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
- Covenant Metabolic Specialists, LLC ( Site 5150), Fort Myers
- Nature Coast Clinical Research - Inverness ( Site 5042), Inverness
- Sanchez Clinical Research ( Site 5144), Miami
- 他4件
被験者募集中第3相
16歳〜80歳 · 全性別 · 2026/10/02更新 · NCT06430801Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- Synergy Healthcare - Bradenton - 17th Avenue West /ID# 284157, Bradenton
- Clinical Research of Osceola /ID# 280593, Kissimmee
- Florida Center For Gastroenterology - Largo /ID# 281059, Largo
- 他3件
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/10/02更新 · NCT07697456A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- Access Research Institute, Brooksville
- Gastro Florida, Clearwater
- Digestive and Liver Center of Florida, P.A., Kissimmee
- 他5件
被験者募集中第4相
18歳〜80歳 · 全性別 · 2026/09/30更新 · NCT06581328Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
- Novum Research /ID# 278128, Clermont
- University of Florida College of Medicine /ID# 266930, Gainesville
- Nature Coast Clinical Research - Inverness /ID# 265874, Inverness
- 他9件
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/09/25更新 · NCT06548542A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
- Green Leaf Clinical Trials, Jacksonville
- Sanchez Clinical Research, Inc, Miami
- Biodax Medical Research Trials, Miami
- 他2件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT07499232A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
- American Institute of Research, Cutler Bay
- Nature Coast Clinical Research, Inverness
- Florida Research Center Inc., Lakewood Rch
- 他2件
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT07196722A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
- West Central Gastroenterology, LLP, d/b/a/ Gastro Florida, Clearwater
- Auzmer Research, Lakeland
- Wellness Clinical Research, Miami Lakes
- 他3件
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/09/25更新 · NCT06233461Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- Research Associates of South Florida - Miami - Southwest 8th Street, Miami
- Gastro Health Research - Miami, Miami
- Orlando Health, Orlando
- 他3件
被験者募集中第3相
18歳〜70歳 · 全性別 · 2026/09/24更新 · NCT06937099Tailored Anti-Inflammatory American Diet for Patients With Crohn's Disease
- University of Miami, Miami
被験者募集中
16歳〜75歳 · 全性別 · 2026/09/24更新 · NCT07671872An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
- Novum Research, LLC-Site Number: 8400003, Clermont
- Sarkis Clinical Trials - Gainesville-Site Number: 8400048, Gainesville
- Clinical Research of Osceola-Site Number: 8400013, Kissimmee
- 他12件
被験者募集中第3相
16歳〜80歳 · 全性別 · 2026/09/23更新 · NCT07184931A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
- Clinical Research of Osceola-Site Number: 8400013, Kissimmee
- Columbus Clinical Services LLc-Site Number: 8400038, Miami
- Bioresearch Partner-Kendale Lakes-Site Number: 8400053, Miami
- 他2件
被験者募集中第3相
16歳〜80歳 · 全性別 · 2026/09/23更新 · NCT07184944A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease
- Arnold Palmer Hospital for Children Center Digestive Health and Nutrition-Orland /ID# 255437, Orlando
被験者募集中第3相
2歳〜17歳 · 全性別 · 2026/09/23更新 · NCT05995353A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
- Clinical Research of Osceola, Kissimmee
- Bioresearch Partner-Kendale Lakes, Miami
- Endoscopic Research Inc, Orlando
- 他1件
被験者募集中第2相
18歳〜85歳 · 全性別 · 2026/09/22更新 · NCT06226883A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
- Gastro Health Research - Miami, Miami
- Ezy Medical Research, Miami Lakes
被験者募集中第2相
18歳〜80歳 · 全性別 · 2026/09/22更新 · NCT07483073A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
- Gastro Health Research - Miami, Miami
- Ezy Medical Research, Miami Lakes
被験者募集中第2相
18歳〜80歳 · 全性別 · 2026/09/22更新 · NCT07483099A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
- Clinical Research of Osceola, Kissimmee
- Endoscopic Research Inc, Orlando
- Alliance Clinical Research of Tampa, LLC, Tampa
被験者募集中第4相
18歳〜70歳 · 全性別 · 2026/09/09更新 · NCT06045754A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
- Florida Research Center Inc., Lakewood Rch
- Sanchez Clinical Research, Inc, Miami
- GCP Clinical Research, Tampa
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/28更新 · NCT07577843Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
- Mayo Clinic Jacksonville, Jacksonville
- Advent Health, Orlando
被験者募集中
18歳以上 · 全性別 · 2026/08/07更新 · NCT05230173Zymfentra (Infliximab-dyyb) REal World Cohort STudy
- University of Miami, Miami
- AdventHealth, Orlando
被験者募集中観察研究
18歳以上 · 全性別 · 2026/08/05更新 · NCT07237516Open-label Single-arm Study to Assess the Efficacy of Mirikizumab in Patients With Inflammatory Strictures Due to CD
- Digestive & Liver Center of Florida, Orlando
被験者募集中第4相
18歳以上 · 全性別 · 2026/07/16更新 · NCT06997965Precise Infliximab Exposure and Pharmacodynamic Control
- Nemours Children's Health System-Jacksonville, Jacksonville
被験者募集中第2/3相
6歳〜22歳 · 全性別 · 2026/05/05更新 · NCT05660746Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
- Clinical Research Of Brandon, LLC, Brandon
- West Central Gastroenterology d/b/a Gastro Florida, Clearwater
- Auzmer Research, Lakeland
- 他7件
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/04/27更新 · NCT06456593Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA) and Diet in Inflammatory Bowel Disease (IBD) Patients
- University of Miami, Miami
被験者募集中第4相
18歳以上 · 全性別 · 2026/03/30更新 · NCT06774079A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease
- Investigational Site Number: 8400017, Kissimmee
- Investigational Site Number: 8400015, Lighthouse PT
- Investigational Site Number 8400028, Miami
- 他3件
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/03/27更新 · NCT06958536A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
- Mirador Therapeutics Selected Site, Miami
- Mirador Therapeutics Selected Site, Miami
- Mirador Therapeutics Selected Site, Miami
- 他3件
被験者募集中第2相
18歳〜80歳 · 全性別 · 2026/03/12更新 · NCT07113522A Pilot Study to Assess the Safety, Tolerability, and Efficacy of Virtual Reality for the Treatment of Abdominal Pain in Quiescent Crohn's Disease
- Mayo Clinic Florida, Jacksonville
被験者募集中
18歳〜70歳 · 全性別 · 2026/02/17更新 · NCT06647615Treatment of Moderate to Severe Refractory Crohn's Disease
- University of Florida, Gainesville
被験者募集中第1/2相
18歳〜65歳 · 全性別 · 2025/12/10更新 · NCT06721962ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。